glp 1 heart Can GLP-1 agonists treat cardiovascular diseases? Schematic presentation of the function

im khc bit l tinh khit, d hp thu hn ng thi cng d dng v tin mang theo khi tp luyn hn

Hy kin nhn v nht qun vi liu lng v thi quen b sung chn

2023, www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management

Introduction What is GLP-1 and why it matters Dietary strategies to increase GLP-1 Lifestyle habits that support GLP-1 Supplements and nutraceuticals Conclusions References Further reading This article explains how specific foods, lifestyle habits, and nutraceuticals can modestly enhance endogenous GLP-1 activity to support appetite regulation and metabolic health

But like any medical treatment, it's not right for everyone

Los resultados prometedores de este estudio llevaron a la aprobacin de la liraglutida por parte de la FDA para reducir el riesgo de eventos cardiovasculares mayores (MACE, por sus siglas en ingls) como ataque cardaco, accidente cerebrovascular y muerte en adultos con diabetes Tipo 2 y enfermedad cardiovascular establecida